IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-29719-1.html
   My bibliography  Save this article

TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease

Author

Listed:
  • Renee E. Vickman

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • LaTayia Aaron-Brooks

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine
    Department of Cancer Biology, Meharry Medical College)

  • Renyuan Zhang

    (Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center)

  • Nadia A. Lanman

    (Purdue University
    Purdue University)

  • Brittany Lapin

    (NorthShore University HealthSystem
    Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic)

  • Victoria Gil

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Max Greenberg

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Takeshi Sasaki

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine
    Mie University Graduate School of Medicine)

  • Gregory M. Cresswell

    (Purdue University
    The George Washington University)

  • Meaghan M. Broman

    (Purdue University)

  • J. Sebastian Paez

    (Purdue University
    Purdue University)

  • Jacqueline Petkewicz

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Pooja Talaty

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Brian T. Helfand

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Alexander P. Glaser

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Chi-Hsiung Wang

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine
    NorthShore University HealthSystem)

  • Omar E. Franco

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Timothy L. Ratliff

    (Purdue University
    Purdue University)

  • Kent L. Nastiuk

    (Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center
    Department of Urology, Roswell Park Comprehensive Cancer Center)

  • Susan E. Crawford

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

  • Simon W. Hayward

    (an Academic Affiliate of the University of Chicago Pritzker School of Medicine)

Abstract

Autoimmune (AI) diseases can affect many organs; however, the prostate has not been considered to be a primary target of these systemic inflammatory processes. Here, we utilize medical record data, patient samples, and in vivo models to evaluate the impact of inflammation, as seen in AI diseases, on prostate tissue. Human and mouse tissues are used to examine whether systemic targeting of inflammation limits prostatic inflammation and hyperplasia. Evaluation of 112,152 medical records indicates that benign prostatic hyperplasia (BPH) prevalence is significantly higher among patients with AI diseases. Furthermore, treating these patients with tumor necrosis factor (TNF)-antagonists significantly decreases BPH incidence. Single-cell RNA-seq and in vitro assays suggest that macrophage-derived TNF stimulates BPH-derived fibroblast proliferation. TNF blockade significantly reduces epithelial hyperplasia, NFκB activation, and macrophage-mediated inflammation within prostate tissues. Together, these studies show that patients with AI diseases have a heightened susceptibility to BPH and that reducing inflammation with a therapeutic agent can suppress BPH.

Suggested Citation

  • Renee E. Vickman & LaTayia Aaron-Brooks & Renyuan Zhang & Nadia A. Lanman & Brittany Lapin & Victoria Gil & Max Greenberg & Takeshi Sasaki & Gregory M. Cresswell & Meaghan M. Broman & J. Sebastian Pae, 2022. "TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29719-1
    DOI: 10.1038/s41467-022-29719-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-29719-1
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-29719-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Julius Gudmundsson & Jon K. Sigurdsson & Lilja Stefansdottir & Bjarni A. Agnarsson & Helgi J. Isaksson & Olafur A. Stefansson & Sigurjon A. Gudjonsson & Daniel F. Gudbjartsson & Gisli Masson & Michael, 2018. "Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA," Nature Communications, Nature, vol. 9(1), pages 1-8, December.
    2. Jianming Zhang & Lingyu Fu & Jingpu Shi & Xin Chen & Yongze Li & Bing Ma & Yao Zhang, 2013. "The Risk of Metabolic Syndrome in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies," PLOS ONE, Public Library of Science, vol. 8(10), pages 1-1, October.
    3. Bianca Cioni & Anniek Zaalberg & Judy R. Beijnum & Monique H. M. Melis & Johan Burgsteden & Mauro J. Muraro & Erik Hooijberg & Dennis Peters & Ingrid Hofland & Yoni Lubeck & Jeroen Jong & Joyce Sander, 2020. "Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion," Nature Communications, Nature, vol. 11(1), pages 1-17, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Cheng Han & Xue He & Xinghai Xia & Yongze Li & Xiaoguang Shi & Zhongyan Shan & Weiping Teng, 2015. "Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 10(8), pages 1-22, August.
    2. Jamal Hallajzadeh & Saeid Safiri & Mohammad Ali Mansournia & Maliheh Khoramdad & Neda Izadi & Amir Almasi-Hashiani & Reza Pakzad & Erfan Ayubi & Mark J M Sullman & Nahid Karamzad, 2017. "Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-21, March.
    3. Jeroen Kneppers & Tesa M. Severson & Joseph C. Siefert & Pieter Schol & Stacey E. P. Joosten & Ivan Pak Lok Yu & Chia-Chi Flora Huang & Tunç Morova & Umut Berkay Altıntaş & Claudia Giambartolomei & Ji, 2022. "Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    4. Judy R. Beijnum & Elisabeth J. M. Huijbers & Karlijn Loon & Athanasios Blanas & Parvin Akbari & Arno Roos & Tse J. Wong & Stepan S. Denisov & Tilman M. Hackeng & Connie R. Jimenez & Patrycja Nowak-Sli, 2022. "Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29719-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.